Toggle navigation
Home
Search
Services
Blog
Contact
About
Malaria Vaccine Research and Development Project
Levine, Myron Max
University of Maryland Baltimore, Baltimore, MD, United States
Search 253 grants from Myron Levine
Search grants from University of Maryland Baltimore
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Sterol Metabolism in Pneumocystis
Imidazoline Receptors in Depression - Clinical Studies
T Cell Immunity to Extracellular Bacteria
Bioenergetic Apparatus in Heart Mitochondria
Immunopathologic Studies
Recently added grants:
Anastrozole in Pulmonary Arterial Hypertension (AIPH2) - DCC
Biology of ?-linked glycosylceramides in the immune system
Genetics of Endocytic Trafficking in the Drosophila Eye
Estrogen signaling and energy metabolism in pulmonary arterial hypertension
Targeted depletion of programmed death-1 positive cells, a method that not only stops autoimmune attack but also preserves adaptive immunity
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project--Cooperative Agreements (U01)
Project #
5U01AI037546-02
Application #
2074330
Study Section
AIDS and Related Research Study Section 3 (ARRC)
Project Start
1994-09-01
Project End
1996-08-31
Budget Start
1995-09-01
Budget End
1996-08-31
Support Year
2
Fiscal Year
1995
Total Cost
Indirect Cost
Institution
Name
University of Maryland Baltimore
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
003255213
City
Baltimore
State
MD
Country
United States
Zip Code
21201
Related projects
NIH 1995
U01 AI
Malaria Vaccine Research and Development Project
Levine, Myron Max / University of Maryland Baltimore
NIH 1994
U01 AI
Malaria Vaccine Research and Development Project
Levine, Myron Max / University of Maryland Baltimore
Comments
Be the first to comment on Myron Levine's grant